[Amikacin in the topical treatment of small losses of substance].
The paper describes the use of aminoglucoside amikacin over 3 years in a group of 187 patients for the topical treatment of skin lesions extending over a maximum 10% of body surface area. The use of amikacin for topical treatment was chosen on the basis of clinical factors; in the majority of cases these were associated to poor circulation in the affected region which created uncertainty as to whether an efficacious dose would be provided by intravenous administration.